These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8448243)

  • 41. Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation.
    Sato Y; Asada Y; Hara S; Marutsuka K; Tamura K; Hayashi T; Sumiyoshi A
    Histopathology; 1999 Jan; 34(1):66-70. PubMed ID: 9934587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
    Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
    Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.
    Scrobohaci ML; Drouet L; Monem-Mansi A; Devergie A; Baudin B; D'Agay MF; Gluckman E
    Thromb Res; 1991 Sep; 63(5):509-19. PubMed ID: 1755004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
    Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Peter J; Strauss RM; Boyer TD; McDonald GB
    Bone Marrow Transplant; 2001 Mar; 27(6):635-9. PubMed ID: 11319594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.
    Ayash LJ; Hunt M; Antman K; Nadler L; Wheeler C; Takvorian T; Elias A; Antin JH; Greenough T; Eder JP
    J Clin Oncol; 1990 Oct; 8(10):1699-706. PubMed ID: 2213105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
    Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
    Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation.
    Skeens MA; McArthur J; Cheifetz IM; Duncan C; Randolph AG; Stanek J; Lehman L; Bajwa R;
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1823-1828. PubMed ID: 27496218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
    Remberger M; Ringdén O
    Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver.
    Remberger M; Ringdén O
    Eur J Haematol; 1997 Oct; 59(4):254-62. PubMed ID: 9338624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.
    Bearman SI; Anderson GL; Mori M; Hinds MS; Shulman HM; McDonald GB
    J Clin Oncol; 1993 Sep; 11(9):1729-36. PubMed ID: 8355040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study.
    Picod A; Bonnin A; Battipaglia G; Giannotti F; Ruggeri A; Brissot E; Malard F; Médiavilla C; Belhocine R; Vekhoff A; Gueye MS; Lapusan S; Adaeva R; Isnard F; Legrand O; Baylatry MT; Joly AC; Labopin M; Duléry R; Mohty M
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1471-1475. PubMed ID: 29477779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.
    Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation.
    Sartori MT; Cesaro S; Peruzzo M; Messina C; Saggiorato G; Calore E; Pillon M; Varotto S; Spiezia L; Cella G
    Pediatr Blood Cancer; 2012 May; 58(5):791-7. PubMed ID: 21674760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.
    Takamura H; Nakanuma S; Hayashi H; Tajima H; Kakinoki K; Kitahara M; Sakai S; Makino I; Nakagawara H; Miyashita T; Okamoto K; Nakamura K; Oyama K; Inokuchi M; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Onishi I; Kayahara M; Tani T; Arai K; Yamashita T; Yamashita T; Kitamura H; Ikeda H; Kaneko S; Nakanuma Y; Matsui O; Ohta T
    Transplant Proc; 2014 Dec; 46(10):3523-35. PubMed ID: 25498084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low, fixed dose defibrotide in management of hepatic veno-occlusive disease post stem cell transplantation.
    Bagal B; Chandrasekharan A; Chougle A; Khattry N
    Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):47-51. PubMed ID: 28460209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation.
    Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Espérou H; Lehn P; Faure P; Drouet L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):1-3. PubMed ID: 2349075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients.
    Yu LC; Malkani I; Regueira O; Ode DL; Warrier RP
    Am J Hematol; 1994 Jul; 46(3):194-8. PubMed ID: 8192148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma thrombopoietin levels in marrow transplant patients with veno-occlusive disease of the liver.
    Oh H; Tahara T; Bouvier M; Farrand A; McDonald GB
    Bone Marrow Transplant; 1998 Oct; 22(7):675-9. PubMed ID: 9818695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The veno-occlusive disease of the liver.
    Baron F; Deprez M; Beguin Y
    Haematologica; 1997; 82(6):718-25. PubMed ID: 9499675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.